semaglutide prostate cancer GLP-1s appear to cut risk. Researchers are asking why and how : NPR Biochemical Recurrence of Prostate Cancer

Why not just use fillers

Diseases with an autoimmune component damage particular cells mitochondria

The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors

Understanding these predispositions should inform a collaborative discussion with your provider about dosing strategy, expected timeline to response, and whether combination approaches align with your genetic profile

Independent reviews continue to show that female-specific health conditions (including menopause, endometriosis, and reproductive health disorders) are among the least studied areas in medicine

A purified anthraquinone-glycoside preparation from rhubarb ameliorates type 2 diabetes mellitus by modulating the gut microbiota and reducing inflammation